EA200600573A1 - Активаторы плазминогена, имеющие сниженную способность связывать лизин - Google Patents

Активаторы плазминогена, имеющие сниженную способность связывать лизин

Info

Publication number
EA200600573A1
EA200600573A1 EA200600573A EA200600573A EA200600573A1 EA 200600573 A1 EA200600573 A1 EA 200600573A1 EA 200600573 A EA200600573 A EA 200600573A EA 200600573 A EA200600573 A EA 200600573A EA 200600573 A1 EA200600573 A1 EA 200600573A1
Authority
EA
Eurasian Patent Office
Prior art keywords
reduced ability
plasminogen activators
bind lysine
lysine
bind
Prior art date
Application number
EA200600573A
Other languages
English (en)
Other versions
EA011156B1 (ru
Inventor
Вольфганг Зенген
Оливер Копс
Винсент Эллис
Original Assignee
Пайон Дойчланд Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пайон Дойчланд Гмбх filed Critical Пайон Дойчланд Гмбх
Publication of EA200600573A1 publication Critical patent/EA200600573A1/ru
Publication of EA011156B1 publication Critical patent/EA011156B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Применение при лечении тромботических заболеваний активаторов плазминогена, которые обладают сниженной способностью связывать лизин.
EA200600573A 2003-09-12 2004-09-13 Активаторы плазминогена, имеющие сниженную способность связывать лизин EA011156B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10342518A DE10342518A1 (de) 2003-09-12 2003-09-12 Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität
PCT/EP2004/010220 WO2005026341A2 (de) 2003-09-12 2004-09-13 Plasminogen-aktivatoren mit verringerter lysin-bindungskapazität

Publications (2)

Publication Number Publication Date
EA200600573A1 true EA200600573A1 (ru) 2006-08-25
EA011156B1 EA011156B1 (ru) 2009-02-27

Family

ID=34305758

Family Applications (2)

Application Number Title Priority Date Filing Date
EA200600573A EA011156B1 (ru) 2003-09-12 2004-09-13 Активаторы плазминогена, имеющие сниженную способность связывать лизин
EA200801861A EA200801861A1 (ru) 2003-09-12 2004-09-13 Активаторы плазминогена, имеющие сниженную способность связывать лизин

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA200801861A EA200801861A1 (ru) 2003-09-12 2004-09-13 Активаторы плазминогена, имеющие сниженную способность связывать лизин

Country Status (14)

Country Link
EP (2) EP1664293A2 (ru)
JP (1) JP2007505079A (ru)
CN (1) CN1849394A (ru)
AU (1) AU2004272731A1 (ru)
BR (1) BRPI0413718A (ru)
CA (1) CA2537696A1 (ru)
DE (1) DE10342518A1 (ru)
EA (2) EA011156B1 (ru)
IL (1) IL173953A0 (ru)
MX (1) MXPA06002756A (ru)
NO (1) NO20061646L (ru)
NZ (1) NZ545825A (ru)
WO (1) WO2005026341A2 (ru)
ZA (1) ZA200602716B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8430749B2 (en) 2001-08-10 2013-04-30 Igt Dynamic casino tracking and optimization
DE10153601A1 (de) 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
DE10342518A1 (de) 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität
IL190184A0 (en) 2008-03-16 2009-02-11 Hadasit Med Res Service tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
FI100403B (fi) * 1988-07-20 1997-11-28 Schering Ag Menetelmä glykosyloitujen tai glykosyloimattomien vampyyrilepakon sylj en plasminogeeniaktivaattoreiden valmistamiseksi
DE3825253A1 (de) * 1988-07-25 1990-02-01 Boehringer Mannheim Gmbh T-pa-derivat und seine herstellung
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US6008019A (en) 1989-02-13 1999-12-28 Schering Aktiengesellschaft Plasminogen activator from saliva of the vampire bat
WO1990009438A1 (en) * 1989-02-13 1990-08-23 Schering Aktiengesellschaft Berlin Und Bergkamen Novel thrombolytic
CA2124937C (en) * 1991-12-16 2001-06-05 William F. Bennett T-pa substitution variants with improved fibrin-specificity
DE4423574A1 (de) * 1994-07-05 1996-01-11 Boehringer Mannheim Gmbh Nicht-glykosylierte Plasminogenaktivator-Derivate und ihre Verwendung bei erhöhtem Blutungsrisiko
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
WO2004096268A2 (de) * 2003-05-02 2004-11-11 Paion Deutschland Gmbh Intravenöse injektion nicht-neurotoxischer plasminogen-aktivatoren zur behandlung von schlaganfall
DE10342518A1 (de) 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität

Also Published As

Publication number Publication date
JP2007505079A (ja) 2007-03-08
IL173953A0 (en) 2006-07-05
WO2005026341A3 (de) 2005-09-01
EP1664293A2 (de) 2006-06-07
NZ545825A (en) 2009-08-28
AU2004272731A1 (en) 2005-03-24
NO20061646L (no) 2006-04-11
ZA200602716B (en) 2007-07-25
EA200801861A1 (ru) 2010-06-30
MXPA06002756A (es) 2007-08-24
CN1849394A (zh) 2006-10-18
CA2537696A1 (en) 2005-03-24
WO2005026341A2 (de) 2005-03-24
DE10342518A1 (de) 2005-05-12
EP2368984A1 (de) 2011-09-28
BRPI0413718A (pt) 2006-10-17
EA011156B1 (ru) 2009-02-27

Similar Documents

Publication Publication Date Title
UA94221C2 (en) Lipocalin protein
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
ATE461217T1 (de) Glp-1-verbindungen
CY1115713T1 (el) Παραγωγα ακρυλαμιδιου ως αντιβιοτικοι παραγοντες
CA115720S (en) Lid
NO20091064L (no) Antistoffer mot IL-17A
ATE515514T1 (de) Verwendungen von säuger-cytokin il-23 ; verwandte reagenzien
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
SE0301653D0 (sv) Novel compounds
TW200509892A (en) Novel aminobenzophenone compounds
UY29249A1 (es) Agentes citotóxicos que comprenden taxanos nuevos
MA32349B1 (fr) Antagonistes de la voie hedgehog a base de phtalazines disubstituees
TW200700064A (en) Novel compounds
WO2007047608A3 (en) Fibrin targeted therapeutics
IL190730A0 (en) Potassium channel inhibitors
MX2007011493A (es) Modalidades antiinflamatorias.
SV2006002296A (es) Tratamiento de mastitis ref. bhc041335-sv
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
SE0301650D0 (sv) Novel compounds
ATE433459T1 (de) Desoxo-nonadepsipeptide
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE410443T1 (de) Heterocyclyl-substituierte nonadepsipeptide
EA200600573A1 (ru) Активаторы плазминогена, имеющие сниженную способность связывать лизин
DE50309647D1 (de) Ng fibrotischer erkrankungen

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU